These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35038954)

  • 1. Vitreous involvement as initial presentation of hereditary transthyretin amyloidosis related to the rare TTR Ile107Met (p.Ile127Met) pathogenic variant.
    Treviño-Herrera AB; Bustamante-Vargas AP; Lisker-Cervantes A; Ríos Y Valles Valles D; Villanueva-Mendoza C; González-Duarte A; Concha-Del-Río LE
    Ophthalmic Genet; 2022 Jun; 43(3):413-419. PubMed ID: 35038954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytodiagnosis and protein typing of amyloid from a vitreous washing: initial diagnostic workup of hereditary amyloidosis.
    Coppock JD; Dusenbery AC; Elghawy O; Fellenstein LA; Frierson HF; Shildkrot Y
    J Am Soc Cytopathol; 2020; 9(3):173-176. PubMed ID: 32113804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene.
    Roe RH; Fisher Y; Eagle RC; Fine HF; Cunningham ET
    Ophthalmology; 2007 Nov; 114(11):e33-7. PubMed ID: 17980738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transthyretin Arg-83 mutation in vitreous amyloidosis].
    Chen L; Lü L; Zhang P; Li Y; Lin J
    Yan Ke Xue Bao; 2008 Mar; 24(1):65-7. PubMed ID: 18709962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oculoleptomeningeal Amyloidosis Secondary to the Rare Transthyretin c.381T>G (p.Ile127Met) Mutation.
    Mathieu F; Morgan E; So J; Munoz DG; Mason W; Kongkham P
    World Neurosurg; 2018 Mar; 111():190-193. PubMed ID: 29277593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of familial amyloid polyneuropathy due to Phe33Val TTR with vitreous involvement as the initial manifestation.
    Kono S; Manabe Y; Tanaka T; Fujii D; Sakai Y; Narai H; Omori N; Ueda M; Ando Y; Abe K
    Intern Med; 2010; 49(12):1213-6. PubMed ID: 20558946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitreous Amyloidosis: Ocular, Systemic, and Genetic Insights.
    Venkatesh P; Selvan H; Singh SB; Gupta D; Kashyap S; Temkar S; Gogia V; Tripathy K; Chawla R; Vohra R
    Ophthalmology; 2017 Jul; 124(7):1014-1022. PubMed ID: 28412068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular Involvement in Hereditary Amyloidosis.
    Minnella AM; Rissotto R; Antoniazzi E; Di Girolamo M; Luigetti M; Maceroni M; Bacherini D; Falsini B; Rizzo S; Obici L
    Genes (Basel); 2021 Jun; 12(7):. PubMed ID: 34206500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elderly onset vitreous opacities as the initial manifestation in hereditary transthyretin (ATTR Val30Met) carries.
    Ishida K; Nishida T; Niimi Y; Suemori S; Mochizuki K; Kawakami H; Kimura A; Hirayama T
    Ophthalmic Genet; 2017; 38(4):387-391. PubMed ID: 28085522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology.
    Skrahina V; Grittner U; Beetz C; Skripuletz T; Juenemann M; Krämer HH; Hahn K; Rieth A; Schaechinger V; Patten M; Tanislav C; Achenbach S; Assmus B; Knebel F; Gingele S; Skrahin A; Hartkamp J; Förster TM; Roesner S; Pereira C; Rolfs A
    Ann Med; 2021 Dec; 53(1):1787-1796. PubMed ID: 34658264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rare transthyretin mutation (Asp18Glu) associated with vitreous amyloid.
    Solano JM; Pulido JS; Salomao DR
    Ophthalmic Genet; 2007 Jun; 28(2):73-5. PubMed ID: 17558848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transthyretin Ala36Pro mutation in a Chinese pedigree of familial transthyretin amyloidosis with elevated vitreous and serum vascular endothelial growth factor.
    Zou X; Dong F; Zhang S; Tian R; Sui R
    Exp Eye Res; 2013 May; 110():44-9. PubMed ID: 23438977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of vitreous amyloidosis without systemic symptoms in familial amyloidotic polyneuropathy.
    Kawaji T; Ando Y; Ando E; Nakamura M; Hirata A; Tanihara H
    Amyloid; 2004 Dec; 11(4):257-9. PubMed ID: 15678760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular Manifestations of Familial Transthyretin Amyloidosis.
    Reynolds MM; Veverka KK; Gertz MA; Dispenzieri A; Zeldenrust SR; Leung N; Pulido JS
    Am J Ophthalmol; 2017 Nov; 183():156-162. PubMed ID: 28911993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three patients of transthyretin amyloidosis in a Japanese family with amyloidogenic transthyretin Thr49Ser (p.Thr69Ser) variant.
    Ikura H; Kitakata H; Endo J; Moriyama H; Sano M; Tsujikawa H; Sawano M; Masuda T; Ohki T; Ueda M; Kosaki K; Fukuda K
    Eur J Med Genet; 2022 Mar; 65(3):104451. PubMed ID: 35149236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunostaining images of vitreous transthyretin amyloid.
    Latasiewicz M; Adan A; Solé M
    Can J Ophthalmol; 2015 Oct; 50(5):384-7. PubMed ID: 26455975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oculoleptomeningeal amyloidosis in 3 individuals with the transthyretin variant Tyr69His.
    Schweitzer K; Ehmann D; Garcia R; Alport E
    Can J Ophthalmol; 2009 Jun; 44(3):317-9. PubMed ID: 19491989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of vitreous amyloidosis and need of surgical reintervention in Portuguese patients with familial amyloidosis ATTR V30M.
    Beirão NM; Matos E; Beirão I; Costa PP; Torres P
    Retina; 2011; 31(7):1373-7. PubMed ID: 21358362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
    Nehashi T; Oikawa M; Amami K; Kanno Y; Yokokawa T; Misaka T; Yamada S; Kunii H; Nakazato K; Ishida T; Takeishi Y
    Int Heart J; 2019 Nov; 60(6):1441-1443. PubMed ID: 31666456
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.